Benefits
Natural source of caffeine and theobromine
Laboratory analysis of white and red Cola nitida and Cola acuminata nuts from Nigeria found 18 to 24 g of caffeine per kg, an estimated 18 to 24 mg per gram (the abstract does not say fresh or dry weight), so by our arithmetic 5 g of nut would supply roughly 90 to 120 mg. A food-safety review names caffeine and theobromine as kola's two main active constituents. Amounts vary by nut and product, so check the label.
Traditional chewing during work and social gatherings
Across West Africa the nut is chewed by laborers and at social gatherings, given as a sign of respect and offered in ceremonies, and it has long been credited with easing fatigue, hunger and thirst. These are traditional and historical uses, not trial results, and many of the old medicinal claims made for kola are exaggerated.
Flavoring use in cola-type drinks
Kola nut extract is used by the food industry as a flavoring, including in cola-type beverages. A safety review estimated intake of the extract at 0.69 mg per kg of body weight a day and judged that its effects likely parallel those of a roughly equivalent dose of caffeine, though it could not define a no-adverse-effect level for kola extract itself.
Effects in rat studies that track its caffeine
Animal work: in rats given kola extract, caffeine extracted from kola, or decaffeinated kola for six weeks, both kola extract and caffeine raised blood pressure and lowered body weight, and the authors concluded kola's effects on blood vessels come from its caffeine. Their extract tested at 51% caffeine. Not tested in people.
Human studies of kola cover drug interactions and patterns of use
The only controlled human study of kola nut gave 12.5 g with an antimalarial drug to 15 healthy men and measured drug blood levels. Other human data are surveys, case reports and observational studies. No trial has tested kola for alertness, exercise or weight, so evidence for those effects comes from caffeine research, not kola.
Mechanism of action
Caffeine is the main active stimulant
A food-safety review judged that the pharmacological and toxicological properties of kola nut extract parallel those of a roughly equivalent dose of caffeine, and a rat study reached the same conclusion for blood vessel effects. How caffeine works, and the human evidence for it, is covered on our caffeine page.
Caffeine bound to catechins in the fresh nut
In freeze-dried fresh kola seeds and a stabilized extract, up to 91% of the caffeine was bound to catechin through hydrogen bonds, while in dried seeds none was bound. The researchers proposed that this may explain differing effects of fresh and dried nuts, an idea that has not been tested in people.
Rich in catechin-type polyphenols
The same analysis that measured caffeine found (+)-catechin at 27 to 37 g per kg, (-)-epicatechin at 20 to 21 g per kg and procyanidins B1 and B2, and kola extracts showed antioxidant capacity in test-tube assays. These are laboratory findings with no human outcome data.
Possible binding of drugs during absorption
When kola nut was taken with the antimalarial halofantrine, drug levels fell while half-life did not change significantly, and the researchers proposed that kola components form a complex with the drug during absorption. This explanation was not directly tested, and no other drug has been tested with kola in a controlled human study.
Clinical trials
Randomized Latin-square crossover study of a single 500 mg dose of the antimalarial drug halofantrine taken alone or with 12.5 g of kola nut, with a 6-week washout; a separate paper from the same 2003 to 2004 study reported heart rhythm (ECG) results. (Kolade et al. 2008, Eur J Clin Pharmacol)
15 healthy male volunteers in Ibadan, Nigeria for the drug-level analysis; the ECG paper describes 18 healthy men.
With kola nut, peak halofantrine levels fell from 179 to 98 ng/ml and total exposure (AUC) from 17,450 to 11,821 ng x h/ml, and its active metabolite fell by about half; time to peak and half-life did not change significantly. In the ECG paper, QTc rose slightly in all three arms without statistical significance, yet its abstract concludes that kola significantly decreased the cardiac effect of halofantrine, a claim its own results do not support. It also gives the kola dose as 12.5 mg (12.5 g in the drug-level paper) and a baseline table of 48 subjects split 17, 11 and 20, which does not match an 18-person crossover. There was no kola-only arm, so neither paper measured kola's own effects.
Case-control study comparing intake of alcohol, kola nut and NSAID painkillers, and smoking, with endoscopy and stomach biopsies, in people with and without non-ulcer dyspepsia in northern Nigeria. (Holcombe et al. 1991, Trans R Soc Trop Med Hyg)
40 patients with strictly defined non-ulcer dyspepsia and 40 matched volunteers without symptoms.
Kola nut ingestion was the only factor that differed significantly between the two groups. Gastritis and H. pylori infection were common in both groups. A case-control design shows an association, not that kola causes indigestion.
Cross-sectional exfoliative cytology study of the palate lining comparing smokers who chewed kola, smokers, kola chewers and men who did neither. (Odukoya et al. 1990, Afr Dent J)
96 Nigerian male volunteers aged 17 to 65.
Smoking and kola chewing both significantly influenced palatal keratinization, which was highest in smokers who also chewed kola, then smokers, then kola chewers, then non-users. The authors suggest kola adds to smoking-related keratinization; the clinical meaning of this marker is not established.
Observational study of saliva antipyrine half-life, a marker of how fast the liver clears some drugs, analyzed by multiple regression against kola use, diet and body measures. (Fraser et al. 1976, Clin Pharmacol Ther)
49 healthy Gambian adults aged 20 to 60 (27 men, 22 women).
Antipyrine half-life averaged 13.6 hours and was longer with cola nut consumption; sex, cola nut use, hemoglobin in women and height in men together explained 36% of the variation. This was a single observational study, so the link is not settled.
Cross-sectional questionnaire study of kola nut use, frequency, amount and reasons among pregnant women in Ibadan, Nigeria. (Atiba et al. 2023, Sci Rep)
478 pregnant women in all trimesters (mean age 28.7).
33.9% reported kola use during pregnancy and 29.3% in the current pregnancy; among current users, 39.3% used it frequently and 32.9% in high quantities. Most users (93.7%) took it to prevent spitting, nausea and vomiting. The survey measured use, not safety or benefit.